Topic Review
Techniques to Assess the Size of KIV-2 CNV
Apolipoprotein(a) (apo(a)) is the protein component that defines lipoprotein(a) (Lp(a)) particles and is encoded by the LPA gene. The apo(a) is extremely heterogeneous in size due to the copy number variation (CNV) in the kringle IV type-2 (KIV-2) domains. Lp(a) concentrations in the blood vary by more than a thousand-fold between individuals, ranging from less than 0.1 to more than 300 mg/dL, depending on the size of apo(a) that is encoded by the LPA gene. The KIV-2 copy number ranges from 1 to >40, and the CNV of KIV-2 shows a >95% heterozygosity in most populations. Screening patients for elevated Lp(a) is strongly encouraged as an effective tool to identify individuals requiring more aggressive lipid-lowering therapy to reduce the CVD risk. Lp(a) levels above 50 mg/dL are correlated with an increased risk for the development of CVD.
  • 319
  • 13 Sep 2023
Topic Review
Freezing of Gait
Parkinson Disease (PD) primarily affects older adults. It is the second-most common neurodegenerative disease after Alzheimer’s disease. Freezing of Gait (FoG) is a symptom present in approximately 80% of advanced-stage PD’s patients. FoG episodes alter the continuity of gait, and may be the cause of falls that can lead to injuries and even death. The recent advances in the development of hardware and software systems for the monitoring, stimulus, or rehabilitation of patients with FoG has been of great interest to researchers because detection and minimization of the duration of FoG events is an important factor in improving the quality of life. 
  • 659
  • 13 Sep 2023
Topic Review
Mechanisms of Relationship between NAFLD and Arterial Hypertension
Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present.
  • 263
  • 13 Sep 2023
Topic Review
Role of Glutathione Precursors in Parkinson’s Disease
Parkinson’s Disease (PD) is a prevalent neurodegenerative illness resulting in progressive motor impairment and cognitive dysfunction. Most PD cases are sporadic, and only a low percentage is related to mutations in a few genes, causing familial PD. As in other prevalent neurodegenerative disorders, aging is the principal risk factor for developing this condition. The protein cysteinome is crucial in cellular regulation and plays unexpected roles in the aging of complex organisms, which show cumulative somatic mutations, telomere attrition, epigenetic modifications, and oxidative dysregulation, culminating in cellular senescence. The cysteine thiol groups are highly redox-active, allowing high functional versatility as structural disulfides, redox-active disulfides, active-site nucleophiles, proton donors, and metal ligands to participate in multiple regulatory sites in proteins. Also, antioxidant systems control diverse cellular functions, including the transcription machinery, which partially depends on the catalytically active cysteines that can reduce disulfide bonds in numerous target proteins, driving their biological integration.
  • 211
  • 13 Sep 2023
Topic Review
PARP Inhibition in Prostate Cancer Patients
The increasing diffusion of genetic analysis regarding the pathogenetic variants (PVs) of genes involved in DNA Damage Repair (DDR) mechanisms and the development of Poly ADP ribose polymerase (PARP) inhibitors (PARPis) led to the first valid precision medicine option tailored toward metastatic prostate cancer (mPC). The concept of anticipation in the systemic treatment of mPC was initially adopted for androgen receptor signaling inhibitors (ARSIs) to describe the expansion of their indications, from the setting of the late-stage second-line treatment of metastatic castration-resistant prostate cancer (mCRPC) to first-line therapy in selected cases. There is already mounting evidence in favor of the anticipation of PARPis in the first line of mCRPC therapy, and further evidence in favor of mHSPC is emerging. 
  • 205
  • 13 Sep 2023
Topic Review
MicroRNAs in Acute Kidney Injury
Acute kidney injury (AKI) is a clinical syndrome where a rapid decrease in kidney function and/or urine output is observed, which may result in the imbalance of water, electrolytes and acid base. It is associated with poor prognosis and prolonged hospitalization. miRNAs are non-coding and single-stranded RNAs that silence their target genes in the post-transcriptional process and are involved in a wide range of biological processes.
  • 497
  • 12 Sep 2023
Topic Review
Neuroprotective Effects of Polyphenols in Neurodegenerative Diseases
It has been shown that polyphenols in various natural sources can provide curative effects against various brain diseases and disorders through neuroprotective effects. These neuroprotective effects are mainly attributed to its ability to cross the blood-brain barrier, remove reactive oxygen species, and cause chelation of metal ions. Polyphenols increase the concentration of neurotrophic factors and bind directly to the membrane receptors of these neurotrophic factors to modulate and activate the signaling cascades that allow the plasticity, survival, proliferation, and growth of neuronal cells, allowing better learning, memory, and cognition. Furthermore, polyphenols do not have serious adverse side effects from their consumption.
  • 330
  • 12 Sep 2023
Topic Review
Toll-like Receptors and Eicosanoids in Sepsis
Sepsis is the leading cause of death from infection. Its incidence is on the rise. Sepsis is characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection, and it can occur after major surgery and injury. TLRs (toll-like receptors) regulate free radical generation, macrophage and leukocyte function, and modulate eicosanoid synthesis, and thus have a critical role in inflammation, immune response, and development and/or recovery from sepsis.
  • 152
  • 12 Sep 2023
Topic Review
Impact of Hemodiafiltration on Biomarkers
Dialysis treatment has improved the survival of patients with kidney failure. However, the hospitalization and mortality rates remain alarmingly high, primarily due to incomplete uremic toxin elimination. High-volume hemodiafiltration (HDF) has emerged as a promising approach that significantly improves patient outcomes by effectively eliminating medium and large uremic toxins, which explains its increasing adoption, particularly in Europe and Japan.
  • 131
  • 12 Sep 2023
Topic Review
Role of Autophagy in Postischemic Brain Neurodegeneration
After cerebral ischemia, autophagy was found to be activated in neuronal, glial and vascular cells. Some studies have shown the protective properties of autophagy in postischemic brain, while other studies have shown completely opposite properties. Thus, autophagy is now presented as a double-edged sword with possible therapeutic potential in brain ischemia. 
  • 196
  • 12 Sep 2023
  • Page
  • of
  • 1352
Video Production Service